Back to funds
View filing
AlphaCentric Advisors LLC
hedge fundUpdated 49 days agoManaged by Alphacentric Advisors Llc • Latest filing Q2 2026
Portfolio value
$118M
Q2 2026
Filings
11
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-7.9%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 11 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $144.9M |
| Q2 2023 | $180.2M |
| Q3 2023 | $176.3M |
| Q4 2023 | $149M |
| Q1 2024 | $165.8M |
| Q2 2024 | $135.8M |
| Q3 2024 | $134.5M |
| Q4 2024 | $100.2M |
| Q4 2025 | $100.3M |
| Q1 2026 | $100.1M |
| Q2 2026 | $118M |
Top holdings
261 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G GILD GILEAD SCIENCES INC | $2.6M | 20.4K | 2.19% | Added(+0.8%) |
| 2 | V VRTX VERTEX PHARMACEUTICALS INC | $2.5M | 5.0K | 2.11% | Added(+1.4%) |
| 3 | I INVH INVITATION HOMES INC | $2.2M | 73.0K | 1.87% | Unchanged |
| 4 | A AZN ASTRAZENECA PLC | $2.2M | 11.4K | 1.83% | Added(+1.4%) |
| 5 | R ROIV ROIVANT SCIENCES LTD | $1.7M | 48.4K | 1.45% | Added(+1.4%) |
| 6 | A ARGX ARGENX SE | $1.7M | 1.8K | 1.42% | Added(+0.7%) |
| 7 | N NBIX NEUROCRINE BIOSCIENCES INC | $1.6M | 9.7K | 1.39% | Added(+1.3%) |
| 8 | I INCY INCYTE CORP | $1.6M | 14.5K | 1.39% | Added(+1.4%) |
| 9 | A AXSM AXSOME THERAPEUTICS INC. | $1.6M | 6.5K | 1.35% | Added(+1.4%) |
| 10 | A APGE APOGEE THERAPEUTICS INC | $1.5M | 11.5K | 1.30% | Added(+1.4%) |
| 11 | ? N/A EURONET WORLDWIDE INC | $1.5M | 20.0K | 1.24% | Trimmed(-28.2%) |
| 12 | ? N/A AEVA TECHNOLOGIES INC | $1.4M | 50.0K | 1.22% | Unchanged |
| 13 | E ETHA ISHARES TR | $1.4M | 5.8K | 1.19% | Trimmed(-51.2%) |
| 14 | ? N/A INVESCO EXCHANGE TRADED FD T | $1.4M | 12.1K | 1.17% | Trimmed(-49.2%) |
| 15 | Q QQQ INVESCO QQQ TR | $1.4M | 1.9K | 1.16% | — |
| 16 | E ETHA INVESCO EXCH TRADED FD TR II | $1.4M | 4.5K | 1.16% | — |
| 17 | ? N/A SAUL CTRS INC | $1.3M | 35.0K | 1.11% | Unchanged |
| 18 | I IONS IONIS PHARMACEUTICALS INC | $1.2M | 15.4K | 1.04% | Trimmed(-21.2%) |
| 19 | A ASND ASCENDIS PHARMA A/S | $1.2M | 4.6K | 1.04% | — |
| 20 | I INSM INSMED INC | $1.2M | 11.4K | 1.03% | Added(+28.4%) |